ArticleOncotarget2018

Mechanism of action and efficacy of LY2109761, a TGF-β receptor inhibitor, targeting tumor microenvironment in liver cancer after TACE.

Xiaojun He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.